Mutual Funds that own NEL ASA
Alfred Berg Gambak
41,303,671
3.76%
6,213,001
3.1%
07/31/2018
Delphi Norge
9,250,000
0.84%
0
2.36%
08/31/2018
Storebrand Vekst
8,147,882
0.74%
180,960
4.69%
08/31/2018
KLP AksjeNorge Indeks
7,389,901
0.67%
0
0.22%
08/31/2018
PNC International Equity Fund
7,225,314
0.66%
7,225,314
0.22%
08/31/2018
6,012,144
0.55%
6,012,144
4.55%
06/30/2017
DNB SMB
4,706,249
0.43%
0
1.89%
07/31/2018
Storebrand Indeks - Norge
4,278,717
0.39%
0
0.24%
08/31/2018
KLP AksjeNorge
4,020,000
0.37%
0
0.2%
08/31/2018
Erste WWF Stock Umwelt
4,000,000
0.36%
0
1.24%
05/30/2018
| Address |
Karenslyst allé 20
Oslo PS 0278
Norway
|
|
Employees
|
- |
| Website |
http://www.nel-asa.com |
| Updated |
07/08/2019 |
| NEL ASA develops diagnostic tests for the early detection of diseases based on gene expression signatures in blood samples. It operates through the In vitro diagnostic (IVD) and hydrogen segments. The In vitro diagnostic segment consists of developing innovative and patient friendly IVD products for early detection of diseases. |
